Bicara Therapeutics Inc (BCAX)

Total Costs & Expenses

$59.95M

Quarterly · Period ending: · USD

BCAX logo

BCAX Total Costs & Expenses

Latest reported$59.95M
BCAX Quarterly Total Costs & Expenses ($8.34M → $59.95M)
High-resolution chart · PNG

BCAX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bicara Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
59,951,000
60,242,000
41,122,000
40,676,000
32,018,000
41,788,000
26,637,000
20,628,000
19,750,000
15,374,000
13,687,000
9,530,000
8,336,000
8,336,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.